|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sica A, Allavena P and Mantovani A: Cancer
related inflammation: The macrophage connection. Cancer Lett.
267:204–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin EY, Nguyen AV, Russell RG and Pollard
JW: Colony-stimulating factor 1 promotes progression of mammary
tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin EY and Pollard JW: Macrophages:
Modulators of breast cancer progression. Novartis Found Symp.
256:158–168. 2004.PubMed/NCBI
|
|
6
|
Yang J, Liao D, Chen C, Liu Y, Chuang TH,
Xiang R, Markowitz D, Reisfeld RA and Luo Y: Tumor-associated
macrophages regulate murine breast cancer stem cells through a
novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells.
31:248–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Donlon TA, Krensky AM, Wallace MR, Collins
FS, Lovett M and Clayberger C: Localization of a human
T-cell-specific gene, RANTES (D17S136E), to chromosome 17q11.2-q12.
Genomics. 6:548–553. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mrowietz U, Schwenk U, Maune S, Bartels J,
Küpper M, Fichtner I, Schröder JM and Schadendorf D: The chemokine
RANTES is secreted by human melanoma cells and is associated with
enhanced tumour formation in nude mice. Br J Cancer. 79:1025–1031.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wertel I, Tarkowski R, Bednarek W and
Kotarski J: Relationship between RANTES and dendritic cells in
ovarian cancer patients. Front Biosci (Elite Ed). 3:227–232. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vaday GG, Peehl DM, Kadam PA and Lawrence
DM: Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Prostate. 66:124–134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soria G and Ben-Baruch A: The inflammatory
chemokines CCL2 and CCL5 in breast cancer. Cancer Lett.
267:271–285. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Milliken D, Scotton C, Raju S, Balkwill F
and Wilson J: Analysis of chemokines and chemokine receptor
expression in ovarian cancer ascites. Clin Cancer Res. 8:1108–1114.
2002.PubMed/NCBI
|
|
13
|
Tang X: Tumor-associated macrophages as
potential diagnostic and prognostic biomarkers in breast cancer.
Cancer Lett. 332:3–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greene FL, Page DL, Fleming ID, et al:
AJCC cancer staging manual6th. Springer-Verlag; New York, NY:
2002
|
|
15
|
Tjiu JW, Chen JS, Shun CT, Lin SJ, Liao
YH, Chu CY, Tsai TF, Chiu HC, Dai YS, Inoue H, et al:
Tumor-associated macrophage-induced invasion and angiogenesis of
human basal cell carcinoma cells by cyclooxygenase-2 induction. J
Invest Dermatol. 129:1016–1025. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siveen KS and Kuttan G: Role of
macrophages in tumour progression. Immunol Lett. 123:97–102. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu H, Xu JB, He YL, Peng JJ, Zhang XH,
Chen CQ, Li W and Cai SR: Tumor-associated macrophages promote
angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol.
106:462–468. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lewis JS, Landers RJ, Underwood JC, Harris
AL and Lewis CE: Expression of vascular endothelial growth factor
by macrophages is up-regulated in poorly vascularized areas of
breast carcinomas. J Pathol. 192:150–158. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nagakawa Y, Aoki T, Kasuya K, Tsuchida A
and Koyanagi Y: Histologic features of venous invasion, expression
of vascular endothelial growth factor and matrix
metalloproteinase-2 and matrix metalloproteinase-9, and the
relation with liver metastasis in pancreatic cancer. Pancreas.
24:169–178. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Soria G, Ofri-Shahak M, Haas I,
Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P,
Meshel T, Shabtai E, Gutman M and Ben-Baruch A: Inflammatory
mediators in breast cancer: Coordinated expression of TNFα &
IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal
transition. BMC Cancer. 11:1302011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hagemann T, Robinson SC, Schulz M, Trümper
L, Balkwill FR and Binder C: Enhanced invasiveness of breast cancer
cell lines upon co-cultivation with macrophages is due to TNF-alpha
dependent up-regulation of matrix metalloproteases. Carcinogenesis.
25:1543–1549. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lim J and Thiery JP:
Epithelial-mesenchymal transitions: Insights from development.
Development. 139:3471–3486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aldinucci D and Colombatti A: The
inflammatory chemokine CCL5 and cancer progression. Mediators
Inflamm. 2014:2923762014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cambien B, Richard-Fiardo P, Karimdjee BF,
Martini V, Ferrua B, Pitard B, Schmid-Antomarchi H and
Schmid-Alliana A: CCL5 neutralization restricts cancer growth and
potentiates the targeting of PDGFRβ in colorectal carcinoma. PLoS
One. 6:e288422011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huber MA, Azoitei N, Baumann B, Grünert S,
Sommer A, Pehamberger H, Kraut N, Beug H and Wirth T: NF-kappaB is
essential for epithelial-mesenchymal transition and metastasis in a
model of breast cancer progression. J Clin Invest. 114:569–581.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang CY, Fong YC, Lee CY, Chen MY, Tsai
HC, Hsu HC and Tang CH: CCL5 increases lung cancer migration via
PI3K, Akt and NF-kappaB pathways. Biochem Pharmacol. 77:794–803.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bond M, Fabunmi RP, Baker AH and Newby AC:
Synergistic upregulation of metalloproteinase-9 by growth factors
and inflammatory cytokines: An absolute requirement for
transcription factor NF-kappa B. FEBS Lett. 435:29–34. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY,
Shun CT, Tsai MF, Chen CH and Yang PC: Tumor-associated
macrophages: The double-edged sword in cancer progression. J Clin
Oncol. 23:953–964. 2005. View Article : Google Scholar : PubMed/NCBI
|
